Yefa Yang
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Papers in
- Hepatology 19
- Hepatocellular Carcinoma Treatment and Prognosis 18
- Liver Disease and Transplantation 3
-
- Ferroptosis and cancer prognosis 2
- Co-authors
- Naijian Ge (21 shared papers)Jinliang Xing (7 shared papers)Zhengfeng Yin (4 shared papers)Haihua Qian (4 shared papers)Mengchao Wu (7 shared papers)Feng Shen (7 shared papers)Lu Wu (6 shared papers)Lehua Shi (3 shared papers)
- Journals
- Oncotarget (2 papers)Cancer Science (2 papers)PLoS ONE (2 papers)Annals of Surgical Oncology (2 papers)Anti-Cancer Agents in Medicinal Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yefa Yang
39 papers receiving 834 citations
Peers
Comparison fields: 5 of 62
- Hepatology 325
- Cancer Research 193
- Oncology 199
- Endocrine and Autonomic Systems 41
- Aging 11
Countries citing papers authored by Yefa Yang
This map shows the geographic impact of Yefa Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yefa Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yefa Yang more than expected).
Fields of papers citing papers by Yefa Yang
This network shows the impact of papers produced by Yefa Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yefa Yang. The network helps show where Yefa Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yefa Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 137 | |
| 2 | 2016 | 78 | |
| 3 | 2018 | 67 | |
| 4 | 2014 | 58 | |
| 5 | 2020 | 57 | |
| 6 | 2015 | 48 | |
| 7 | 2012 | 46 | |
| 8 | 2011 | 36 | |
| 9 | 2012 | 31 | |
| 10 | 2011 | 28 | |
| 11 | 2014 | 28 | |
| 12 | 2012 | 26 | |
| 13 | 2010 | 23 | |
| 14 | 2015 | 21 | |
| 15 | 2011 | 20 | |
| 16 | 2016 | 18 | |
| 17 | 2021 | 13 | |
| 18 | 2014 | 11 | |
| 19 | 2015 | 11 | |
| 20 | 2015 | 10 |
About Yefa Yang
Yefa Yang is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Epidemiology, having authored 40 papers that have together received 840 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease Diagnosis and Treatment (3 papers), Cancer, Lipids, and Metabolism (3 papers), Cancer Mechanisms and Therapy (3 papers), Telomeres, Telomerase, and Senescence (3 papers), Liver Disease and Transplantation (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Hepatology (325 citations), Cancer Research (193 citations), Oncology (199 citations), Endocrine and Autonomic Systems (41 citations) and Aging (11 citations). Yefa Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Naijian Ge, Jinliang Xing, Zhengfeng Yin, Haihua Qian, Mengchao Wu, Feng Shen, Lu Wu, Lehua Shi, Han-Qiang Liu and Xiaoyan Kang. Their work appears in journals such as Oncotarget, Cancer Science, PLoS ONE, Annals of Surgical Oncology and Anti-Cancer Agents in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.